Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Mol Cell Cardiol. 2016 Sep 20;100:35–42. doi: 10.1016/j.yjmcc.2016.09.010

Figure 3.

Figure 3

Sarcomere length and contractile properties of isolated cardiomyocytes from control and c26 tumor-bearing mice with or without treatment. A) Sarcomere length (μm), B) Peak shortening (PS%), C) Negative velocity (−dL/dt), D) Positive velocity (+dL/dt), E) Time to peak shortening 90% (TPS 90), and F) Time to relaxation 90% (TR 90) were determined at day 21 post injection. Bars are used to demonstrate significant effects between groups. p<0.05 was considered statistically significant.